Federal Supply Schedule V797D70174

Award Date 6/1/17
Last Date to Order 5/31/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 IB, which covers Drugs, Pharmaceuticals, and Hematology Related Products. The contract was awarded to HLS Therapeutics Inc., a for-profit manufacturer, on July 1, 2022 by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract has a ceiling value of $13,848,500.00 and a period of performance through June 30, 2027. It is a multiple award...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency. The contract, awarded to Enzyvant Therapeutics Inc., has a ceiling value of $2,100,100.00 and a period of performance ending on July 31, 2023. The purpose of the contract is to provide drugs, pharmaceuticals, and hematology-related products under the 65 I B Federal Supply Class. The contract is a multiple-award vehicle, meaning it can...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Vertex Pharmaceuticals Incorporated. The contract is for the provision of "Drugs, Pharmaceuticals, & Hematology Related Products" under the Pharmaceuticals and Drugs (FSS-61-IB) contract vehicle. The contract has a ceiling value of $205,530,618.00 and a period of performance from May 1, 2024 to April 30, 2029....
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. federal government. The contract, valued at up to $9,000,000.00, was awarded to Tarsus Pharmaceuticals Inc. on January 15, 2024 and has an ultimate completion date of January 14, 2029. The FSS contract is for 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS. The awarded prime contractor, Tarsus...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Tonix Medicines, Inc. The contract has a period of performance from August 1, 2024 to July 31, 2029 and a ceiling value of $250,000.00. The contract is for the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS. As an FSS contract, it allows for the purchase of the awarded products and services by various federal...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract was awarded to Amarin Pharma, Inc., a for-profit organization, with a period of performance from September 1, 2024 to August 31, 2029. The contract has a ceiling value of $1,844,760.00 and covers the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS contract...
The federal contract IDV award 36F79720D0150 is a Federal Supply Schedule contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. government. The contract was awarded to Assertio Therapeutics Inc., a for-profit manufacturer of goods, on July 1, 2020 with a ceiling value of $51,322,640.00 and a period of performance through December 31, 2025. The contract is classified under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule and...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products. The contracting agency is the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 12 (VISN 12). The prime contractor is Reata Pharmaceuticals, Inc., a for-profit organization. The contract has a ceiling value of $25,000.00 and a period of performance ending on October 23, 2023. It is a multiple...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA). The prime contractor is Amphastar Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical goods. The $58,244,500 multiple award contract has a period of performance through January 14, 2027 and aims to procure a broad range of drug,...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs to Day One Biopharmaceuticals, Inc. The contract has a ceiling value of $225,000.00 and a period of performance through December 6, 2029. The contract is for the provision of Drugs, Pharmaceuticals, & Hematology Related Products under FSS Category 65 I B. As a multiple award FSS contract, it allows the VA and other federal agencies to procure these medical products and...

The federal contract IDV award, V797D70174, is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Sarepta Therapeutics, Inc. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) schedule. The contract has a ceiling value of $225,000.00 and a period of performance ending on May 31, 2026. The contract was awarded on June 1, 2017 and does not have any set-aside requirements. The scope of the contract includes the delivery of pharmaceutical and drug products to support the agency's healthcare operations, with a focus on life cycle changes and permanent price adjustments for 15 national drug codes (NDCs). The contract serves as a multiple-award vehicle, allowing the agency to issue task orders against the schedule as needed to meet its drug and pharmaceutical requirements.

Generated 7/17/25, 5:16 PM